Results 131 to 140 of about 2,433 (185)

Pharmacogenetic Analysis of TPMT and NUDT15 in a European Pediatric Cohort with IBD and Autoimmune Diseases: Frequency Data and Clinical Relevance. [PDF]

Genes (Basel)
Pau A, Galliano I, Ponte A, Clemente A, Dini M, Calvi C, Montanari P, Pizzol A, Gambarino S, Calvo PL, Bergallo M.   +10 more
europepmc   +1 more source

Pharmacogenomics of anticancer drugs: Personalising the choice and dose to manage drug response [PDF]

, 2020
Carr, Daniel, Pirmohamed, Munir, Turner, Richard M   +2 more
core   +1 more source

OP035 NUDT15 variants contribute to thiopurine-induced myelosuppression in European populations [PDF]

Journal of Crohn's and Colitis, 2018
G Walker, J Harrison, M Voskuil, G Heap, N Heerasing, P Hendy, J Koskela, M Daly, H Sokol, D McGovern, R Weersma, C Bewshea, M Weedon, J Goodhand, N Kennedy, T Ahmad   +15 more
openaire   +1 more source

รายการยาที่อยู่ในแนวทางปฏิบัติเภสัชพันธุศาสตร์ในด้านคำแนะนำการรักษา Medications in Pharmacogenetics Guidelines Related to Therapeutic Recommendations [PDF]

                          บทคัดย่อ การทบทวนวรรณกรรมนี้ มีจุดประสงค์เพื่อรวบรวมข้อมูลรายการยาที่มีแนวทางปฏิบัติเภสัชพันธุศาสตร์ในด้านคำแนะนำการรักษาจากกลุ่มผู้เชี่ยวชาญ เช่น CPIC, DPWG, RNPGx และ CPNDS เพื่อใช้เป็นแนวทางในการปฏิบัติงานทางด้านเภสัชพันธ ...
Charoenyingwathana, Angkana, Kunawaradisai, Nonglex, Phanaksri, Teva, Saisawang, Chonticha, Sukpan, Panupong, Vongpoon, Naya   +5 more
core   +1 more source

The multifaceted regulatory roles of Nudix hydrolases in cancer and their therapeutic potential. [PDF]

Front Oncol
Pan J, Yang J, Wang K.
europepmc   +1 more source

NUDT15 Genetic Polymorphism as a Risk Factor for Early Neutropenia During Valganciclovir Prophylaxis in Lung Transplant Patients. [PDF]

Transpl Infect Dis
Katsube Y, Umemura K, Urabe Y, Ono M, Katada Y, Hira D, Ohsumi A, Nakajima D, Tsuda M, Nakagawa S, Mizuno T, Nagao M, Date H, Terada T.   +13 more
europepmc   +1 more source

Influence of xanthine oxidase and inosine monophosphate dehydrogenase polymorphisms on 6-mercaptopurine treatment response in pediatric acute lymphoblastic leukemia. [PDF]

Sci Rep
Sabirova Z, Boucetta MTE, Bensouyad RR, Gagné V, Théorêt Y, Nava T, Leclerc JM, Laverdière C, Sinnett D, Tran TH, Krajinovic M.   +10 more
europepmc   +1 more source

Addressing genetic diversity and health inequities: RELIVAF's proposal for Latin American pharmacogenomic guidelines. [PDF]

Front Pharmacol
Quiñones LA, Martínez MF, Vargas R, Cerpa LC, López-Cortés A, González-Martínez F, Fonseca D, Duconge J, Varela NM, Lares-Asseff I, Redal MA, Esperón P, Ríos-Santos F, Rendón AL, Serrano R, Ortega E, Sullón-Dextre L, Sanchez E, Arias ML, Remírez D, Morales A.   +20 more
europepmc   +1 more source

The role of pharmacogenetics in the therapy regimen of acute lymphoblastic leukemia in children: recent discoveries and future perspectives. [PDF]

Pharmacol Rep
Szoszkiewicz A, Światłowska A, Derwich K, Jamsheer A, Rubiś B, Bienert A.   +5 more
europepmc   +1 more source

Prevalence of actionable pharmacogenomic variants in Brazilian patients with cancer. [PDF]

Front Pharmacol
Schuch JB, Botton MR, De Baumont AC, Curzel G, Cadore NA, Bordignon C, Rosa ML, Vasconcellos VF, Barros LAR, Souza CP, Barra WF, Louzeiro DLC, Notari A, de Menezes JJ, Liedke PER, Bertollo GA, Gongora ABL, Ascenco HG, Kowalski-Neto E, Oppermann CP, Werutsky G, Santos EM, Brandão FS, Freitas-Junior R, Nogueira-Rodrigues A, Mancini ALC, Bessel M, Macedo GS, Rosa DD.   +28 more
europepmc   +1 more source